Cabot Corporation (CBT)
NYSE: CBT · Real-Time Price · USD
72.00
-0.18 (-0.25%)
Aug 1, 2025, 4:00 PM - Market closed
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2016 - 2020 |
Net Income | 433 | 380 | 445 | 209 | 250 | -238 | Upgrade |
Depreciation & Amortization | 148 | 151 | 144 | 146 | 160 | 158 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | 2 | -7 | - | 129 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 197 | - | - | Upgrade |
Loss (Gain) on Equity Investments | -7 | -6 | -5 | -10 | -3 | -3 | Upgrade |
Stock-Based Compensation | 26 | 25 | 20 | 23 | 21 | 9 | Upgrade |
Other Operating Activities | 35 | 72 | -111 | -10 | 73 | 160 | Upgrade |
Change in Accounts Receivable | -13 | -26 | 153 | -287 | -215 | 126 | Upgrade |
Change in Inventory | -5 | 41 | 96 | -259 | -174 | 114 | Upgrade |
Change in Accounts Payable | -14 | 42 | -152 | 115 | 167 | -55 | Upgrade |
Change in Income Taxes | 9 | 3 | -4 | 15 | 14 | -5 | Upgrade |
Change in Other Net Operating Assets | -4 | 10 | 7 | -32 | -36 | -18 | Upgrade |
Operating Cash Flow | 608 | 692 | 595 | 100 | 257 | 377 | Upgrade |
Operating Cash Flow Growth | -8.16% | 16.30% | 495.00% | -61.09% | -31.83% | 3.86% | Upgrade |
Capital Expenditures | -320 | -241 | -244 | -211 | -195 | -200 | Upgrade |
Cash Acquisitions | - | - | - | -9 | - | -92 | Upgrade |
Divestitures | - | - | 6 | 79 | - | - | Upgrade |
Sale (Purchase) of Real Estate | - | - | 7 | 18 | - | - | Upgrade |
Other Investing Activities | 6 | 6 | 17 | 5 | 9 | 4 | Upgrade |
Investing Cash Flow | -314 | -235 | -214 | -118 | -186 | -288 | Upgrade |
Short-Term Debt Issued | - | - | 24 | 276 | 58 | - | Upgrade |
Long-Term Debt Issued | - | 15 | 84 | 394 | 200 | 444 | Upgrade |
Total Debt Issued | 166 | 15 | 108 | 670 | 258 | 444 | Upgrade |
Short-Term Debt Repaid | - | -128 | -197 | - | - | -19 | Upgrade |
Long-Term Debt Repaid | - | -30 | -90 | -372 | -222 | -410 | Upgrade |
Total Debt Repaid | -68 | -158 | -287 | -372 | -222 | -429 | Upgrade |
Net Debt Issued (Repaid) | 98 | -143 | -179 | 298 | 36 | 15 | Upgrade |
Issuance of Common Stock | 9 | 20 | 4 | 6 | 6 | 3 | Upgrade |
Repurchase of Common Stock | -204 | -172 | -98 | -53 | -3 | -44 | Upgrade |
Common Dividends Paid | -95 | -93 | -88 | -84 | -80 | -80 | Upgrade |
Other Financing Activities | -35 | -27 | -42 | -22 | -19 | -26 | Upgrade |
Financing Cash Flow | -227 | -415 | -403 | 145 | -60 | -132 | Upgrade |
Foreign Exchange Rate Adjustments | -60 | -57 | 54 | -91 | 8 | 25 | Upgrade |
Net Cash Flow | 7 | -15 | 32 | 36 | 19 | -18 | Upgrade |
Free Cash Flow | 288 | 451 | 351 | -111 | 62 | 177 | Upgrade |
Free Cash Flow Growth | -29.24% | 28.49% | - | - | -64.97% | 27.34% | Upgrade |
Free Cash Flow Margin | 7.37% | 11.29% | 8.93% | -2.57% | 1.82% | 6.77% | Upgrade |
Free Cash Flow Per Share | 5.22 | 8.10 | 6.21 | -1.95 | 1.09 | 3.13 | Upgrade |
Cash Interest Paid | 82 | 82 | 85 | 46 | 41 | 48 | Upgrade |
Cash Income Tax Paid | 136 | 136 | 140 | 129 | 93 | 71 | Upgrade |
Levered Free Cash Flow | 208.25 | 362.88 | 305.25 | -30 | -9 | 174.38 | Upgrade |
Unlevered Free Cash Flow | 255.13 | 413.5 | 361.5 | 5 | 21.63 | 207.5 | Upgrade |
Change in Net Working Capital | 7 | -86 | -114 | 308 | 235 | -148 | Upgrade |
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.